|
Insulin and Glucagon Physiology |
|
1
Insulin Biosynthesis, Secretion, Structure, and Structure-Activity Relationships
|
Michael Weiss, Donald F. Steiner, M.D. and Louis H. Philipson, M.D., Ph.D |
|
2
Glucagon Physiology
|
Niyaz R. Gosmanov, M.D., Adair R. Gosmanov, M.D., Ph.D., F.A.C.E. and John E. Gerich, M.D. |
|
3
THE INSULIN RECEPTOR AND ITS SIGNAL TRANSDUCTION NETWORK
|
Pierre De Meyts, MD, PhD, F.A.C.E |
|
Pathogenesis of Diabetes |
|
4
Classification of Diabetes Mellitus
|
Curtis Triplitt, PharmD, Carolina Solis-Herrera, MD, Charles Reasner, M.D., Ralph A. DeFronzo, M.D. and Eugenio Cersosimo, M.D. PhD |
|
5
Pathogenesis of Type 1A Diabetes
|
Aaron Michels, MD and Peter Gottlieb, MD |
|
6
Pathogenesis of Type 2 Diabetes Mellitus
|
Eugenio Cersosimo, M.D. PhD, Curtis Triplitt, PharmD, Lawrence J. Mandarino, Ph.D. and Ralph A. DeFronzo, M.D. |
|
7
Atypical Forms of Diabetes
|
Tiinamaija Tuomi, MD, PhD, Paivi J. Miettinen, MD, PhD, Liisa Hakaste, MD, PhD and Leif Groop, MD, PhD |
|
7.1
Diabetes Mellitus After Solid Organ Transplantation – An Overview
|
Ashvin Kamath, Phuong Mai Pham and Phuong-Thu Pham |
|
8
Metabolic Syndrome
|
David W. Lam and Derek LeRoith, M.D., PhD. |
|
8
Etiology and Pathogenesis of Diabetes Mellitus IN Children
|
Berrin Ergun-Longmire, M.D. and Noel Keith Maclaren, M.D. |
|
9b
Diabetes in the Elderly
|
Anna Milanesi, MD PhD and Jane E. Weinreb, M.D. |
|
9a
Evaluation and Treatment of Polycystic Ovary Syndrome
|
Richard S. Legro, M.D. |
|
Diabetes Treatment – Diagnosis |
|
12
Assessing Insulin Sensitivity and Resistance in Humans
|
Ranganath Muniyappa, M.D.,Ph.D., Ritu Madan, MBBS, MD and Michael J. Quon MD, PhD |
|
12b
Pancreatic Islet Function Tests
|
Marisa E. Desimone, M.D. and Ruth S. Weinstock, M.D., PhD |
|
Modalities for Treatment of Diabetes |
|
14
INSULIN – PHARMACOLOGY, THERAPEUTIC REGIMENS AND PRINCIPLES OF INTENSIVE INSULIN THERAPY
|
Thomas Donner, M.D. |
|
15
Oral and Injectable (Non-insulin) Pharmacological Agents for Type 2 Diabetes
|
Joseph L. Evans, Ph.D., Börk Balkan, Ph.D., Eunice Chuang, MD and Robert J. Rushakoff, M.D. |
|
16
NON-PHARMACEUTICAL INTERVENTION OPTIONS FOR TYPE 2 DIABETES: Diets and Dietary Supplements (Botanicals, Antioxidants, and Minerals)
|
Joseph L. Evans, Ph.D. and Miki Bahng, Ph.D. |
|
Diabetes Treatment – Strategies |
|
17
The Management of Type 1 Diabetes
|
Savitha Subramanian, MD, David Baidal, Jay S. Skyler, M.D. and Irl B. Hirsch, M.D. |
|
17.1
MANAGEMENT OF TYPE 2 DIABETES: SELECTING AMONGST AVAILABLE PHARMACOLOGICAL AGENTS
|
Tricia Santos Cavaiola, MD and Jeremy H. Pettus, MD |
|
18
Nutritional Recommendations for Individuals with Diabetes
|
Alison Gray, RD, MBA |
|
19
Management of Diabetes and Hyperglycemia in Hospitalized Patients
|
Leonor Corsino, MD, MHS, FACE, Ketan Dhatariya and Guillermo Umpierrez |
|
20
Management of Diabetes in Pregnancy
|
Erin Keely, MD, FRCPC and Linda A. Barbour, M.D., M.S.P.H. |
|
20a
Management of Type-1 and Type-2 Diabetes Mellitus in Children
|
Berrin Ergun-Longmire, M.D. and Noel Keith Maclaren, M.D. |
|
22
Monitoring Technologies – Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control
|
Kathleen Dungan, M.D. |
|
23
Islet Transplantation
|
Lorenzo Piemonti and Antonello Pileggi, M.D., Ph.D. |
|
23.1
Transplantation of the Pancreas
|
Ugo Boggi, Gabriella Amorese, Margherita Occhipinti and Piero Marchetti |
|
23.5
Surgical Treatment of obesity
|
Paul O'Brien, MD, FRACS |
|
23.7
Changing the Course of Disease in Type 1 Diabetes
|
Dana VanBuecken, ARNP, Sandra Lord, MD and Carla J. Greenbaum, MD |
|
Diabetic Complications |
|
24
Hyperglycemic Crises: Diabetic Ketoacidosis (DKA), And Hyperglycemic Hyperosmolar State (HHS)
|
Adair R. Gosmanov, M.D., Ph.D., F.A.C.E., Elvira O. Gosmanova, M.D., F.A.S.N. and Abbas E. Kitabchi, M.D., Ph.D., M.A.C.E. |
|
25
Hypoglycemia During Therapy of Diabetes
|
Philip Cryer, M.D. |
|
25.1
NON-DIABETIC HYPOGLYCEMIA
|
Marisa E. Desimone, M.D. and Ruth S. Weinstock, M.D., PhD |
|
26
Hypertension in Diabetes
|
Ankur Jindal, Syed Hasan Naqvi, Muhammad Waqar Salam and James R. Sowers, M.D. |
|
27
ROLE OF GLUCOSE AND LIPIDS IN THE CARDIOVASCULAR DISEASE OF PATIENTS WITH DIABETES
|
Kenneth R Feingold, MD and Carl Grunfeld, MD, PhD |
|
27.1
Management of Dyslipidemia in the Elderly
|
Dan Streja, , MD, FRCPC, FACP, FACE, and Elani Streja, Ph.D. |
|
29
Diabetic Retinopathy
|
Jay M. Stewart, M.D., Marco Coassin, M.D., Ph.D. and Daniel M. Schwartz, M.D. |
|
30
Diabetic Nephropathy and Treatment of Hypertension
|
Allen I. Arieff, M.D., F.A.C.P. |
|
31
Diabetic Neuropathies
|
Aaron Vinik, MD, PhD, FCP, MACP, FACE, Carolina Casellini, M.D. and Marie-Laure Nevoret, M.D. |
|
31.1
THE DIABETIC FOOT
|
Andrew JM Boulton, MD, DSc, FICP, FACP, FRCP |
|
32
Sexual Dysfunction in Diabetes
|
Tom F. Lue, M.D., William O. Brant, M.D., Alan Shindel, M.D. and Anthony J. Bella, M.D. |
|
Tumor Syndromes |
|
33.1
Insulinomas
|
Aaron Vinik, MD, PhD, FCP, MACP, FACE, Eric Feliberti, MD, FACS and Roger R Perry, M.D., FACS |
